1. COVID‐19 and immunosuppressive therapy in dermatology.
- Author
-
Schwartz, Robert A., Pradhan, Swetalina, Murrell, Dedee F., Jafferany, Mohammad, Olisova, Olga Y., Lomonosov, Konstantin M., Lotti, Torello, and Goldust, Mohamad
- Subjects
- *
COVID-19 pandemic , *COVID-19 treatment , *COVID-19 , *IMMUNOSUPPRESSIVE agents , *SKIN diseases - Abstract
Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID‐19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID‐19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID‐19 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF